NOM Startup Program - Ameratat

In the final year of my PhD, I began setting up Ameretat as a company and participated in the VentureLab program as well as various pitch competitions and startup contests. Through that, I also got to know people at NOM, and they pointed me toward the Startup Program.

Validation is essential, but as a medtech startup, things often move more slowly than you’d like. It takes a lot of time to find the right contacts, connections, and partners, and I was looking for a way to do that in a well-structured manner. Participating in the Startup Program was perfect timing.

So far only the first track on validation, but I plan to join the Investor Program as well.

That structure and a solid framework to work from are incredibly valuable, because they allow you to clearly demonstrate the steps you’ve taken. That’s also highly relevant information for potential investors.

As a medtech startup, you naturally conduct fewer validation interviews than other types of startups, but I find the structured approach and methodology we learned very pleasant and practical to apply.

During the program, you learn how to validate your product in a uniform and structured way. It’s a method that has proven to work. If I hadn’t participated in the program, I would have had to reinvent the wheel myself in that regard.

There are always moments when it feels like you’re stuck, but that’s exactly when you need to look for creative solutions. In my case, for example, it was quite difficult to find the right contact details, so I built a tool to scrape that data from the internet. There’s always a way to solve challenges.

Absolutely. The quality of the program is very high, and beyond what you learn, you also receive a lot of personal support, practical advice on specific challenges you’re facing, and help finding the right contacts. Especially for early-stage startups, there’s really no reason not to participate.